• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 27 of 100
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
Health
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
By The Associated PressDecember 8, 2021
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health
Omicron vaccine to begin clinical trial in South Africa
By Jeremy KahnDecember 6, 2021
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
Commentary
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
The most important meeting yet for global pandemic response—and drugmakers
Commentary
The most important meeting yet for global pandemic response—and drugmakers
By Nicole Hassoun and Kaushik BasuNovember 29, 2021
To avoid the superbug pandemic, we must fix the business model for new antibiotics
Commentary
To avoid the superbug pandemic, we must fix the business model for new antibiotics
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
DeepMind and now Isomorphic Laboratories CEO Demis Hassabis
Tech
DeepMind spins out new Alphabet company focused on drug discovery
By Jeremy KahnNovember 4, 2021
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
Features
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
By Erika FryOctober 30, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By David MeyerOctober 27, 2021
Robots work in a warehouse
Newsletters
What’s big in A.I. this year
By Jeremy KahnOctober 12, 2021
Merck asks FDA to authorize its breakthrough COVID antiviral pill
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By Matthew Perrone and The Associated PressOctober 11, 2021
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
Health
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
By Suzi Ring and BloombergOctober 11, 2021
Merck's antiviral pill for COVID-19
Health
Everything to know about Merck’s COVID antiviral pill
By Emily MullinOctober 5, 2021
CVS Health is about to turn hundreds of its drugstores into health care super-clinics
Health
CVS Health is about to turn hundreds of its drugstores into health care super-clinics
By Shawn TullyOctober 4, 2021
Pfizer vaccine
Health
What comes next for COVID booster shots after the FDA panel hedges on Pfizer
By Sy MukherjeeSeptember 17, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Politics
Tesla and 113 other companies paid no current federal income tax, but they still aren’t the biggest threats to the federal deficit, think tank warnsplaceholder alt text
By Sasha RogelbergOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.